It is known that actinomycin D blocks the action of parathyroid hormone on bone (Eisenstein et al., 1964; Rasmussen et al., 1964) while not interfering with its actions on renal calcium and phosphate handling. Actinomycin D does not prevent secretion of parathyroid hormone (Tashjiian, 1965) . It is possible that the RNA inhibitors act initially by preventing parathyroid hormone induced calcium release from bQne, leading to a fall in serum calcium with a resulting increase in parathyroid hormone secretion. This extra parathyroid hormone (unable to act on bone) could be responsible for hypophosphataemia and hypocalciuria, by an action on tubular reabsorption. This aspect may be clarified somewhat by parathyroid hormone assay and studies of renal phosphate clearance.
The similarities between the effects of actinomycin D on our patients, and mithramycin (Ryan and Schwartz, 1969) , and the actions of calcitonin in Paget's disease as described by Bijvoet and Jansen (1967) and Bijvoet et al. (1968) , suggest that RNA inhibitors may act by potentiating or stimulating the action of calcitonin. Calcitonin assay may shed some light on this aspect.
A direct action of RNA inhibitors on osteoblasts appears quite likely, particularly in view of the findings of reduced formation of chondroitin sulphate in rats treated with actinomycin D (Hulth and Lindberg, 1968) and the finding of inhibition of bone growth in children treated with this agent for renal tumours (Aarskog and Hexeberg, 1968) . However, the finding of such a pronounced fall in urinary calcium even after the serum calcium level has returned to normal suggests that a humoral mechanism is also likely to be involved. Actinomycin D is a toxic drug, a factor which must be a major one in the limitation of the use of this drug in Paget's disease, where long-standing treatment would be required. (Pitney, 1968) . In Uganda the syndrome was formerly known as "big spleen disease" and has been associated with lymphocytic infiltration of the hepatic sinusoids (Hamilton et al., 1965 (Hamilton et al., , 1966 Marsden et al., 1965) . Malarial infection has been implicated in its aetiology on the basis of several kinds of indirect evidence. There is a close geographic coincidence of tropical splenomegaly syndrome with malarious areas, and patients having it show high titres of malaria antibodies (Gebbie et al., 1964; Hamilton et al., 1965; Marsden et al., 1967) . Sickle-cell trait, which confers considerable protection against severe Plasmodium falciparum malaria, occurs rarely if at all in these patients . More compelling evidence is contained in the reports of improvement in hepatosplenomegaly and anaemia in patients with tropical splenomegaly syndrome following long-term malaria prophylaxis (Lowenthal and Hutt, 1968; Watson-Williams and Allan, 1968; Sagoe, 1970 (Table I) . Table II ). 
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(1)(6) . Symptoms.-At the end of the trial patients were asked whether they felt better, the same, or worse since the trial began. The assessment of symptoms included feeling of wellbeing, appetite, fatigue, weakness, fevers, and splenic pain. In general, patients initially sought help for two different reasons: most complained of chronic abdominal discomfort directly attributable to the large spleen, whereas some had symptoms of anaemia. Relief of symptoms (Table IV) was 20 FEBRUARY 1971 therapy is necessary before definite clinical responses are observed. Significant reduction in spleen size, substantial symptomatic relief, and improvement in haemoglobin levels were found. Further analysis of the patients who responded to malaria prophylaxis showed that younger patients responded better than older ones. The poorer response in the elderly may be related to secondary changes, such as fibrosis and adhesions in spleens which have been enlarged for many years.
Our study differed from that carried out in West Africa as follows: (1) primaquine and chloroquine rather than proguanil were used, (2) the design of the two trials was different, (3) the criteria for patient selection in our series included hepatic sinusoidal lymphocytosis, and (4) the degree of splenomegaly and haematological abnormalities was less pronounced than in the West African patients. Nevertheless, the studies have shown that two different malarial prophylactic regimens will produce substantial improvement in tropical splenomegaly syndrome.
As soon as the results of this trial were analysed and significant differences were observed, those receiving placebo tablets were placed on primaquine and chloroquine. Six thus far evaluated have already shown substantial reduction of spleen size over a period of six months. The spleen size reduction time curves of most of our treated patients were still continuing downward after 12 months of therapy, and it seems clear that continued malaria prophylaxis is required. The optimal duration of antimalarial administration required for control of tropical splenomegaly syndrome has yet to be established. Both in our experience and in that from West Africa patients have relapsed after discontinuing their medication even after long periods of successful treatment. It may be that patients require prophylaxis as long as they remain exposed to malarial infection.
The pathogenesis of tronical splenomegaly syndrome and its relation to malaria is still unclear. These patients appear to have generally normal immune responses (Ziegler et al., 1969) , but produce a large amount of macroglobulin (Wells, 1968) . Electron microscopy studies of the liver have shown mature lymphocytes in close association with hypertrophied Kupffer cells, an appearance which is very suggestive of a cellular immune response (Hutt and Fluck, 1970) . These observations have led to speculation that there is a persistent antigenic stimulus which results in a benign lymphoproliferative disorder predominately affecting the spleen and liver. The stimulus may be due to the malaria parasite itself, malaria antigen in an altered form, or possibly even to a form of malaria antibody. As malaria parasite frequency and density rates are very low in this condition and overt attacks of malaria are very rare, the immune response can be said to be effective in this respect.
In any event, if chronic malarial parasitaemia of a very low grade provides the antigenic stimulus leading to tropical splenomegaly syndrome, then the beneficial effect of malaria prophylaxis can be readily accounted for by the elimination of parasites from the blood. This seems to be the simplest explanation of the clinical observations at present.
The best treatment for tropical splenomegaly syndrome has not been fully settled. Splenectomy should be reserved, at least in the tropics, for special indications (Hamilton et al., 1967; Paliwoda and Hutt, 1968) . It is possible that more potent cytotoxic agents such as methotrexate or chlorambucil have a role in severe hypersplenism in which splenectomy cannot be performed. Prolonged therapy with antimalarial drugs (chloroquine or proguanil), however, seems to be the most reasonable and effective treatment for uncomplicated cases of tropical splenomegaly syndrome at the present time.
Introduction
The tropical splenomegaly syndrome has been the subject of several reviews during the past two years (Pitney, 1968; British Medical Yournal, 1967 , 1969 . Previous studies in Zambia showed that tropical splenomegaly syndrome occurring there was similar to that described in other parts of Africa (Lowenthal et al., 1966) and also that long-term antimalarial prophylaxis with proguanil was beneficial (Lowenthal and Hutt, 1968 (1965) . The assay was repeated in seven cases after therapy, and in three of these a third estimation was made after a further interval. For the purpose of providing control values IgM was assayed in two other groups of patients. The first incluided patients with moderate to massive splenomegaly due to chronic myeloid leukaemia (3 cases), primary myeloid metaplasia (2), schistosomiasis (5), tropical splenomegaly syndrome without hepatic sinusoidal lymphocytosis (4), hepatic cirrhosis (6), and one case each of tuberculosis, amyloidosis, and con-
